E-LIB Suche - Ergebnisse für: Avorn, Jerry

1

Pragmatic trial evaluating the impact of simulation trainin..:

Lauffenburger, Julie C. ; DiFrancesco, Matthew F. ; Bhatkhande, Gauri...
Journal of the American Geriatrics Society. 72 (2024) 5 - p. 1420-1430 , 2024

Link: https://doi.org/10.1111/..

2

US public investment in development of mRNA covid-19 vaccin..:

Lalani, Hussain S ; Nagar, Sarosh ; Sarpatwari, Ameet...
BMJ. , 2023

Link: https://doi.org/10.1136/..

3

Prescribing decision making by medical residents on night s..:

Lauffenburger, Julie C. ; Coll, Maxwell D. ; Kim, Erin...
Medical Education. 56 (2022) 10 - p. 1032-1041 , 2022

Link: https://doi.org/10.1111/..

4

New Drug Postmarketing Requirements and Commitments in the ..:

Moneer, Osman ; Brown, Beatrice L. ; Avorn, Jerry...
Drug Safety. 45 (2022) 4 - p. 305-318 , 2022

Link: https://doi.org/10.1007/..

5

Overcoming Decisional Gaps in High-Risk Prescribing by Juni..:

Lauffenburger, Julie C ; DiFrancesco, Matthew F ; Barlev, Renee A...
JMIR Research Protocols. 11 (2022) 4 - p. e31464 , 2022

Link: https://doi.org/10.2196/..

6

Characteristics of Clinical Trials Launched Early in the CO..:

Raimond, Véronique ; Mousquès, Julien ; Avorn, Jerry.
Journal of Law, Medicine & Ethics. 49 (2021) 1 - p. 139-151 , 2021

Link: https://doi.org/10.1017/..

7

Pursuing Value-Based Prices for Drugs: A Comprehensive Comp..:

BENDICKSEN, LIAM ; ROME, BENJAMIN N. ; AVORN, JERRY.
The Milbank Quarterly. 99 (2021) 4 - p. 1162-1197 , 2021

Link: https://www.jstor.org/st..

8

Pursuing Value‐Based Prices for Drugs: A Comprehensive Comp..:

BENDICKSEN, LIAM ; ROME, BENJAMIN N. ; AVORN, JERRY.
The Milbank Quarterly. 99 (2021) 4 - p. 1162-1197 , 2021

Link: https://doi.org/10.1111/..

9

Discovery and Development of Pregabalin (Lyrica): The Role ..:

Barenie, Rachel ; Darrow, Jonathan ; Avorn, Jerry.
Neurology. 97 (2021) 17 - p. , 2021

Link: https://doi.org/10.1212/..

10

Characteristics of US Patients and Prescribers Using Hydrox..:

Rome, Benjamin N. ; Avorn, Jerry ; Kesselheim, Aaron S.
Journal of General Internal Medicine. 36 (2021) 12 - p. 3918-3921 , 2021

Link: https://doi.org/10.1007/..

11

A Multi-modal Approach to Evaluate the Impact of Risk Evalu..:

Sarpatwari, Ameet ; Mitra-Majumdar, Mayookha ; Bykov, Katsiaryna...
Drug Safety. 44 (2021) 7 - p. 743-751 , 2021

Link: https://doi.org/10.1007/..

12

Public funding for transformative drugs: the case of sofosb..:

Barenie, Rachel E. ; Avorn, Jerry ; Tessema, Frazer A..
Drug Discovery Today. 26 (2021) 1 - p. 273-281 , 2021

Link: https://doi.org/10.1016/..

13

US Taxpayers Heavily Funded the Discovery of COVID‐19 Vacci..:

Lalani, Hussain S. ; Avorn, Jerry ; Kesselheim, Aaron S.
Clinical Pharmacology & Therapeutics. 111 (2021) 3 - p. 542-544 , 2021

Link: https://doi.org/10.1002/..

14

Non-warfarin oral anticoagulant copayments and adherence in..:

Rome, Benjamin N. ; Gagne, Joshua J. ; Avorn, Jerry.
American Heart Journal. 233 (2021) - p. 109-121 , 2021

Link: https://doi.org/10.1016/..

15

Accounting for US public funding in drug development: how c..:

Sarpatwari, Ameet ; Avorn, Jerry ; Kesselheim, Aaron S
BMJ: British Medical Journal. 371 (2020) - p. 1-4 , 2020

Link: https://www.jstor.org/st..